Face Memory in Idiopathic Parkinson’s Disease Moderated by Sex and Encoding Duration
Abstract
We examined face memory deficits in patients with Idiopathic Parkinson’s disease (IPD) with specific regard to the moderating role of sex and the different memory processes involved. We tested short- and long-term face recognition memory in 18 nonclinical participants and 18 IPD-patients matched for sex, education and age. We varied the duration of item presentation (1, 5, 10s), the time of testing (immediately, 1hr, 24hrs) and the possibility to re-encode items. In accordance with earlier studies, we report face memory deficits in IPD. Moreover, our findings indicate that sex and encoding conditions may be important moderator variables. In contrast to healthy individuals, IPD-patients cannot gain from increasing duration of presentation. Furthermore, our results suggest that IPD leads to face memory deficits in women, only.
Die Studie untersuchte Gesichtergedächtnisdefizite bei Patienten mit idiopathischem Parkinson-Syndrom (IPS). Unter der speziellen Berücksichtigung der moderierenden Funktion des Geschlechts und der verschiedenen involvierten Gedächtnisprozesse, wurden Kurz- und Langzeit-Gesichtergedächtnis bei 18 nicht-klinischen Probanden und 18 IPS-Patienten getestet. Beide Gruppen waren vergleichbar hinsichtlich des Geschlechts, der Bildung und des Alters. Wir variierten die Dauer der Item-Präsentation (1, 5, 10 s), den Abrufzeitpunkt (unmittelbar, 1 Std, 24 Std), sowie die Möglichkeit, die Items zu re-enkodieren. In Übereinstimmung mit früheren Studien können Gesichtergedächtnisdefizite bei Patienten mit IPS berichtet werden. Überdies deuten die Ergebnisse darauf hin, dass Geschlecht und Enkodierbedingung wichtige Moderatorvariablen sind. Im Unterschied zu gesunden Probanden, können Patienten mit IPS nicht von einer erhöhten Enkodierdauer profitieren. Darüber hinaus weisen die Ergebnisse darauf hin, dass IPS lediglich bei betroffenen Frauen zu Gesichtergedächtnisdefiziten führt.
References
2005). Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: A positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. Journal of Neuroscience, 25, 2471 – 2477.
(2005). A systematic review of prevalence studies of dementia in Parkinson’s disease. Movement Disorders, 20, 1255 – 1263.
(2011). Striatal dopamine and the interface between motivation and cognition. Frontiers in Psychology, 2, article 163.
(1999). M.I.N.I. Mini International Neuropsychiatric Interview, German Version 5.0.0 DSM IV. München: Psychiatrische Universitätsklinik München.
(2009). Sex influences on the neurobiology of learning and memory. Learning & Memory, 16, 248 – 266.
(2006). Wechsler Intelligenztest für Erwachsene (WIE). Deutschsprachige Bearbeitung und Adaptation des WAIS-III von David Wechsler. Frankfurt: Harcourt Test Services.
(2000). Regensburger Wortflüssigkeits-Test (Handbuch mit Protokollbögen). Göttingen: Hogrefe.
(2006a). Face memory in MRI-negative and MRI‐positive temporal lobe epilepsy. Epilepsia, 47, 1904 – 1914.
(2006b). Sex differences in face recognition memory in patients with temporal lobe epilepsy, patients with generalized epilepsy, and healthy controls. Epilepsy & Behavior, 9, 593 – 600.
(1983). Contributions to Neuropsychological Assessment. New York: Oxford University Press.
(2010). Statistik für Human- und Sozialwissenschaftler (7. Aufl.). Berlin: Springer.
(2000). Pathoanatomy of Parkinsons disease. Journal of Neurology, 247, 3 – 10.
(2011). Verbal memory in drug-naive, newly diagnosed Parkinson’s disease. The retrieval deficit hypothesis revisited. Neuropsychology, 25, 114 – 124.
(1999). Frontal cortex contributes to human memory formation. Nature Neuroscience, 2, 311 – 314.
(2004). Cerebral atrophy in Parkinson’s disease with and without dementia: A comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain, 127, 791 – 800.
(2005). Object memory and perception in the medial temporal lobe: an alternative approach. Current Opinion in Neurobiology, 15, 730 – 737.
(2006). Parkinson Neuropsychometric Dementia Assessment (PANDA). Lengerich: Pabst Science Publishers.
(1988). Statistical power analysis for the behavioral sciences. New York: Erlbaum.
(2000). Sex differences in human neonatal social perception. Infant Behavior and Development, 23, 113 – 118.
(2000). Understanding memory for faces in Parkinson’s disease: The role of configural processing. Neuropsychologia, 38, 837 – 847.
(1991). Perception and memory for faces in Parkinson’s disease. Neuropsychologia, 29, 785 – 802.
(1997). Cognitive deficits in Parkinsons disease. Journal of Neurology, 244, 2 – 8.
(2003). An evaluation of two commonly used tests of unfamiliar face recognition. Neuropsychologia, 41, 713 – 720.
(2003). Dementia associated with Parkinsons disease. The Lancet Neurology, 2, 229 – 237.
(2005). The role of the striatal dopamine transporter in cognitive aging. Psychiatry Research: Neuroimaging, 138, 1 – 12.
(2001). Frontal lobes and human memory. Insights from functional neuroimaging. Brain, 124, 849 – 881.
(2003). Greater orbitofrontal activity predicts better memory for faces. European Journal of Neuroscience, 7, 2755 – 2758.
(1999). Diagnostic criteria for Parkinson disease. Archives of Neurology, 56, 33 – 39.
(2001). Material-specific lateralization in the medial temporal lobe and prefrontal cortex during memory encoding. Brain, 124, 1841 – 1854.
(2009). The role of the basal ganglia in learning and memory: Neuropsychological studies. Behavioral Brain Research, 199, 53 – 60.
(2002). Cognitive impairments in advanced PD without dementia. Neurology, 59, 1320 – 1324.
(2000). Die Wechsler-Memory-Scale-revised. Deutschsprachige Adaptation. Bern: Huber.
(1996). Are perception and memory for faces influenced by a specifc age at onset factor in Parkinson’s disease? Neuropsychologia, 34, 315 – 320.
(1995). Beck-Depressions-Inventar (BDI); Testhandbuch (2. Aufl.). Bern: Hans Huber.
(1999). Anhedonia – a general nosology surmounting correlate of a dysfunctional dopaminergic reward system? Nervenarzt, 70, 391 – 398.
(2009). Sex differences in cognitive functions. Acta Psychologica Sinica, 41, 1081 – 1090.
(2008). Sex differences in episodic memory. Current Directions in Psychological Science, 17, 52 – 56.
(2002). Sex differences in episodic memory: The influence of intelligence. Journal of Clinical and Experimental Neuropsychology, 24, 107 – 114.
(1995). Hospital Anxiety and Depression Scale (HADS-D) – Deutsche Version. Göttingen: Hogrefe.
(1967). Parkinsonism: Onset, progression and mortality. Neurology, 17, 427 – 42.
(1999). Post mortem studies in Parkinsons disease – is it possible to detect brain areas for specific symptoms? Journal of Neural Transmission Supplementum, 56, 1 – 29.
(2008). Dopamin im Gehirn. Teil 2: Seine Funktion und Bedeutung für neuropsychiatrische Erkrankungen. Psychopraxis, 1, Wien: Springer.
(2000). Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson’s disease. Neurology, 54, 1482 – 1487.
(2002). Functional imaging studies of dopamine system and cognition in normal aging and Parkinson’s disease. Neuroscience & Biobehavioral Reviews, 26, 785 – 793.
(2006). Side and type of motor symptom influence cognition in Parkinson’s disease. Movement Disorders, 21, 1947 – 1953.
(1998). Hemispheric specialization in human dorsal frontal cortex and medial temporal lobe for verbal and nonverbal memory encoding. Neuron, 20, 927 – 936.
, et al. (2007). Recognition memory for unfamiliar faces in Parkinson’s disease: Behavioral and electrophysiologic measures. Parkinsonism and Related Disorders, 13, 157 – 164.
(2011). Apathy and depression: Separate factors in Parkinson’s disease. Journal of the International Neuropsychological Society, 17, 1058 – 1066.
(2007). Individual faces elicit distinct response patterns in human anterior temporal cortex. Proceedings of the National Academy of Sciences of the USA, 104, 20600 – 20605.
(2002). Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biological Psychiatry, 52, 759 – 763.
(1981). “Das State-Trait-Angstinventar (Testmappe mit Handanweisung, Fragebogen STAI-G Form X 1 und Fragebogen STAI-G Form X 2)”. Weinheim: Beltz.
(1989). Cognitive impairments associated with early Parkinson’s disease. Neurology, 39, 557 – 561.
(2003). Relation between clinical characteristics of Parkinson’s disease and cognitive decline. Journal of Clinical and Experimental Neuropsychology, 25, 94 – 109.
(2004). Selective sex differences in declarative memory. Memory & Cognition, 32, 1160 – 1169.
(2002). Dopaminergic modulation of cortical function in patients with Parkinson’s disease. Annals of Neurology, 51, 156 – 164.
(2010). Gender differences in Parkinson’s disease: clinical characteristics and cognition. Movement Disorders, 25, 2695 – 2703.
(1968). Visual recognition and recall after right temporal-lobe excision in man. Neuropsychologia, 6, 191 – 209.
(2002). Material-specific deficits in “remembering” in patients with unilateral temporal lobe epilepsy and excisions. Neuropsychologia, 40, 1335 – 1342.
(2001). Striatal dopamine transporters and cognitive functioning in healthy men and women. American Journal of Psychiatry, 158, 1492 – 1499.
(2003). Memory function in normal aging. Acta Neurologica Scandinavica, 107, 7 – 13.
(1997). The Betula prospective cohort study: Memory, health, and aging. Aging Neuropsychology and Cognition, 4, 1 – 32.
(1992). Fronto-striatal cognitive deficits at different stages of Parkinsons disease. Brain, 115, 1727 – 1751.
(2010). Parkinson’s disease in women: A call for improved clinical studies and for comparative effectiveness research. Maturitas, 65, 352 – 358.
(2010). Quantitative Methoden. Einführung in die Statistik für Psychologen und Sozialwissenschaftler. Heidelberg: Springer.
(2007). Women remember more faces than men do. Acta Psychologica, 124, 344 – 355.
(2008). Cognitive impairment in 873 patients with idiopathic Parkinsons disease. Results from the German Study on Epidemiology of Parkinsons Disease with Dementia (GEPAD). Journal of Neurology, 255, 255 – 264.
(2007). Sex differences in the effect of acute tryptophan depletion on declarative episodic memory: a pooled analysis of nine studies. Neuroscience and Biobehavioral Reviews, 31, 516 – 529.
(1995). Structural differences in the cerebral cortex of healthy female and male subjects: A magnetic resonance imaging study. Psychiatry Research, 61, 129 – 135.
(1992). Wortschatztest (WST). Weinheim: Beltz.
(1988). Pragmatics of measuring recognition memory: Applications to dementia and amnesia. Journal of Experimental Psychology: General, 117, 34 – 50.
(2005). Temporal lobe atrophy on MRI in Parkinsons disease with dementia. A comparison with Alzheimer disease and dementia with Lewy bodies. Neurology, 64, 861 – 865.
(1990). Memory and learning in early Parkinsons disease: Evidence for a “frontal lobe syndrome”. Brain and Cognition, 13, 211 – 232.
(1993). Side of onset of motor symptoms influences cognition in Parkinson’s disease. Annals of Neurology, 34, 579 – 584.
(2014). Imaging early consolidation of perceptual learning with face stimuli during rest. Brain and Cognition, 85, 170 – 179.
(1984). Recognition memory test. Windsor (UK): NFER-Nelson.
(1998). Material-specific lateralization of prefrontal activation during episodic encoding and retrieval. Neuroreport, 9, 3711 – 3717.
(2011). Sex influence on face recognition memory moderated by presentation duration and re-encoding. Neuropsychology, 25, 806 – 813.
(2000). Recognition memory impairment in Parkinsons disease: Power and meta-analyses. Neuropsychology, 14, 233 – 246.
(2005). Reward-related FMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-dependent long-term memory formation. Neuron 45, 459 – 467.
(2003). Gender differences in the processing of standardized emotional visual stimuli in humans: A functional magnetic resonance imaging study. Neuroscience Letters, 348, 41 – 45.
(2010). Progression from unilateral to bilateral parkinsonism in early Parkinson disease: Implication of mesocortical dopamine dysfunction by PET. The Journal of Nuclear Medicine, 51, 1250 – 1258.
(